Estimation of US patients with cancer who may respond to cytotoxic chemotherapy

Edward B. Maldonado, Scott Parsons, Emerson Y. Chen, Alyson Haslam, Vinay Prasad

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Aims, patients & methods: In this retrospective review, we sought to estimate the proportion of patients in the USA with advanced or metastatic cancer who are eligible for and may respond to recommended first-line cytotoxic chemotherapy based on National Comprehensive Cancer Network treatment guidelines. Results: Among 609,640 patients, we estimate 479,823 (78.7%, 95% CI: 78.6-78.8%) may be eligible for cytotoxic chemotherapy while 189,159 out of 609,640 patients (31.0%, 95% CI: 30.9-31.1%) may have achieved treatment response. The average objective response rate from these regimens was 48.6% (range 9.2 to 90.6%). Conclusion: Given the large role of cytotoxic agents in cancer, drug development in this space may remain of interest in specific cancer types, and regulatory approval of novel oncology drugs may justify head-to-head comparisons against cytotoxic regimens. Lay abstract This retrospective review sought to estimate patients in the USA with advanced or metastatic cancer who are eligible for and may respond to recommended first-line cytotoxic chemotherapy based on National Comprehensive Cancer Network treatment guidelines. Given our results and the large role of chemotherapy in cancer, drug development in this space may remain of interest in specific cancer types and regulatory approval of novel oncology drugs may justify head-to-head comparisons against cytotoxic regimens.

Original languageEnglish (US)
Article numberFSO600
JournalFuture Science OA
Volume6
Issue number8
DOIs
StatePublished - Sep 2020

Keywords

  • chemotherapy
  • cytotoxic
  • oncology drugs

ASJC Scopus subject areas

  • Biotechnology

Fingerprint Dive into the research topics of 'Estimation of US patients with cancer who may respond to cytotoxic chemotherapy'. Together they form a unique fingerprint.

Cite this